期刊文献+

妊娠期分化型甲状腺癌的诊治进展

Progress of Diagnosis and Treatment for Differentiated Thyroid Carcinoma in Pregnancy
原文传递
导出
摘要 目的探讨妊娠期分化型甲状腺癌的诊治进展。方法复习妊娠期分化型甲状腺癌诊治的相关文献,进行回顾性分析和总结。结果妊娠期分化型甲状腺癌禁忌行核素扫描和放射性碘治疗,在妊娠中期行使手术相对安全,推迟到分娩后手术并不影响产妇的预后,但需在妊娠全程严密监测肿瘤的生长速度。结论妊娠期分化型甲状腺癌的诊治变得更复杂,其是内分泌科、外科及妇产科医生共同面临的挑战。 Objective To explore the progress of diagnosis and treatment for differentiated thyroid carcinoma (DTC) in pregnancy. Methods The literatures on studying the diagnosis and treatment of DTC in pregnancy were reviewed and analyzed retrospectively. Results Radionuclide scanning and radioiodine (131I) administration during pregnancy were contraindicated. Surgery during the second trimester was considered safe. Monitoring of pregnancy must be strict during each trimester if surgery was delayed until after delivery. Conclusions Pregnancy makes the diagnosis and treatment of DTC become more complicated, the diagnosis and treatment of DTC during pregnancy present a challenging situation for the endocrinologists, surgeon, and obstetrician.
出处 《中国普外基础与临床杂志》 CAS 2013年第9期1001-1005,共5页 Chinese Journal of Bases and Clinics In General Surgery
关键词 妊娠 分化型甲状腺癌 甲状腺激素 治疗 Pregnancy Differentiated thyroid carcinoma Thyroid hormone Treatment
  • 相关文献

参考文献35

  • 1Mazzaferri EL. Approach to the pregnant patient with thyroid cancer [J]. J Clin Endocrinol Metab, 2011,96(2): 265-272.
  • 2Lee ML, Chen GG, Vlantis AC, et al. Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL [ J ]. Cancer J, 2005, 11(2): 113-121.
  • 3Antico-Arciuch VG, Dima M, Liao XH, et al. Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the develo- pment of follicular carcinomas with a higher incidence in females [J]. Oncogene, 2010, 29(42): 5678-5686.
  • 4Zeng Q, Chen G, Vlantis A, et al. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas [J]. J Pathol, 2008, 214(4): 425-433.
  • 5Chen GG, Vlantis AC, Zeng Q, et al. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer [ J ]. Curr Cancer Drug Targets, 2008, 8(5): 367-377.
  • 6Vivacqua A, Bonofiglio D, Albanito L, et al. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30 [J]. Mol Pharmacol, 2006, 70(4): 1414-1423.
  • 7McTiernan AM, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors [J]. Am J Epidemiol, 1984, 120(3): 423-435.
  • 8Mack W J, Preston-Martin S, Bemstein L, et al. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females [ J ]. Cancer Epidemiol Biomarkers Prev, 1999, 8(11): 991-997.
  • 9Pham TM, Fujino Y, Mikami H, et al. Reproductive and mens- trual factors and thyroid cancer among Japanese women: the Japa- nese Collaborative Cohort Study [ J ]. J Womens Health (Larchmt), 2009, 18(3): 331-335.
  • 10Yasmeen S, Cress R, Romano PS, et al. Thyroid cancer in preg- nancy [ J ]. Int J Gynaecol Obstet, 2005, 91 (1): 15-20.

二级参考文献17

  • 1ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 2Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin End~rinol Metab, 2007,92 (8 Suppl) :S1-47.
  • 3Stagnaro-Green A, Aba|ovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid, 2011,21 : 1081-1125.
  • 4Yah YQ, Dong ZL, Dong L, et al. Trimester- and method-specific reference intervals for thyroid tests in pregnant Chinese women: methodology, euthyroid definition, and iodine status can influence the setting of reference intervals. Clin Endocrinol ( Oxf), 2011,74 : 262- 269.
  • 5Baloch Z, Carayon P, Coute-Devoix B, eta|. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 2003, 13: 3- 126.
  • 6Guan H, Shan Z, Teng X, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH : results of a follow-up study in areas with different iodine intakes. Clin Endocrinol ( Oxf), 2008,69 : 136-141.
  • 7Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4) , and thyroid antibodies in the United States population ( 1988 to 1994) : National Health and Nutrition Examination Smwey ( NHANES III). J Clin Endocrinol Metab, 2002,87:489-499.
  • 8Arnaud-Lopez L, Usala G, Ceresini G, et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet, 2008,82 : 1270-1280.
  • 9Glinoer D, Spencer CA. Serum TSH determinations in pregnancy: how, when, and why? Nat Rev Endocrinol, 2010,6:526-529.
  • 10Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med, 2012,366 : 493-501.

共引文献854

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部